Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 14 tags : Therapeutics save search
Viridian Therapeutics to Participate in 32nd Annual Oppenheimer Healthcare Conference on March 15
Published: 2022-03-14 (Crawled : 14:20) - globenewswire.com
VRDN | $13.04 -8.49% -9.28% 770K
|
Health Care and Social Assistan...
|
| O: 0.25%
H: 1.7%
C: -1.68%
conference therapeutics
Sigilon Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
Published: 2022-03-14 (Crawled : 01:00) - biospace.com/
SGTX | $22.47 -2.56% 0.0% 0
|
Health Technology
|
| O: 1.53%
H: 4.89%
C: -3.01%
financial results therapeutics report results
Curie Therapeutics Appoints Georgette Verdin as Chief People Officer
Published: 2022-03-14 (Crawled : 00:00) - biospace.com/
MSFT | News 4 | $408.94 0.34% 0.33% 14M
|
Technology Services
|
| O: -2.7%
H: 0.0%
C: 0.0%
therapeutics
Alterity Therapeutics to Participate in the Sachs Associates 5th Annual Neuroscience Innovation Forum
Published: 2022-03-14 (Crawled : 00:00) - alteritytherapeutics.com
ATHE | $2.33 9.39% 8.58% 170K
|
Health Technology
|
| O: -0.6%
H: 4.21%
C: -0.72%
therapeutics
Agile Therapeutics Announces Closing of $4.85 Million Registered Direct Offering
Published: 2022-03-14 (Crawled : 23:00) - globenewswire.com
AGRX | $0.37 0.0% 95K
|
Health Technology
|
| O: -1.66%
H: 11.07%
C: 6.71%
offering therapeutics
DiaMedica Therapeutics Provides a Business Update and Announces Fourth Quarter 2021 Financial Results
Published: 2022-03-14 (Crawled : 22:00) - biospace.com/
DMAC | $2.5 3.31% 3.2% 7.4K
|
Health Technology
|
| O: -3.54%
H: 2.88%
C: -5.71%
financial results therapeutics results
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-03-14 (Crawled : 22:00) - globenewswire.com
TVTX | $5.46 -4.88% -5.13% 2M
|
Health Technology
|
| O: 1.09%
H: 0.37%
C: -0.5%
therapeutics nasdaq report grant granted
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-03-14 (Crawled : 21:00) - arcutis.com
ARQT | $8.76 0.23% 0.23% 2M
|
Health Technology
|
| O: 1.08%
H: 0.88%
C: 0.44%
therapeutics nasdaq report iot grant granted
Aldeyra Therapeutics to Participate in Fireside Chat at the Oppenheimer 32nd Annual Healthcare Conference
Published: 2022-03-14 (Crawled : 13:30) - biospace.com/
ALDX | $3.93 0.51% 0.51% 570K
|
Health Technology
|
| O: -0.24%
H: 2.44%
C: -8.31%
health thc conference therapeutics
Fulcrum Therapeutics® Presents Data Highlighting Reachable Workspace (RWS) as Relevant Functional Endpoint in Facioscapulohumeral Muscular Dystrophy (FSHD) at MDA Clinical and Scientific Conference
Published: 2022-03-14 (Crawled : 13:30) - biospace.com/
FULC | $7.275 -2.22% -2.27% 350K
|
Health Technology
|
| O: -1.62%
H: 0.57%
C: -2.35%
therapeutics fun muscular dystrophy space conference work spac tiona
Cyclo Therapeutics Provides Business Update and Reports Full Year 2021 Financial Results
Published: 2022-03-14 (Crawled : 13:30) - biospace.com/
CYTH | $1.21 7.94% 21K
|
Professional, Scientific, and T...
|
| O: -3.17%
H: 1.15%
C: -8.85%
financial results therapeutics report results
F-star Therapeutics Reports Full-Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-14 (Crawled : 13:30) - biospace.com/
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: 1.34%
H: 0.46%
C: -8.58%
financial results star therapeutics report results
CAMP4 Therapeutics Appoints Veteran Drug Developer Ann Barbier, M.D., Ph.D. as Chief Medical Officer
Published: 2022-03-14 (Crawled : 12:30) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
drug therapeutics
Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors Following Announcement of Update from Bristol-Myers Squibb and Nektar on the PIVOT-IO-001 Phase 3 Trial
Published: 2022-03-14 (Crawled : 12:30) - biospace.com/
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: -54.79%
H: 0.0%
C: 0.0%
io-001 announcement trial conference therapeutics phase 3
Abeona Therapeutics Achieves Target Enrollment in Pivotal Phase 3 VIITAL™ Study of EB-101 in RDEBTopline data from VIITAL™ expected in the third quarter of 2022
Published: 2022-03-14 (Crawled : 12:30) - biospace.com/
ABEO | News | $3.165 -7.19% -7.74% 2.2M
|
Health Technology
|
| O: -6.93%
H: 0.0%
C: 0.0%
eb-101 therapeutics topline phase 3 enroll
Arch Therapeutics Partners with Centurion Therapeutics to Expand Access to AC5® Advanced Wound System
Published: 2022-03-14 (Crawled : 12:00) - globenewswire.com
ARTH | $1.14 -17.78% 320
|
Manufacturing
|
| O: 0.0%
H: 8.89%
C: 0.0%
ac5 system therapeutics
Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-14 (Crawled : 11:00) - globenewswire.com
VERV | $6.59 -4.22% -4.4% 1M
|
Professional, Scientific, and T...
|
| O: -8.55%
H: 0.0%
C: 0.0%
financial results therapeutics report results
Everest Medicines Enters into Agreement with Calliditas Therapeutics, Expanding Territory License to Develop and Commercialize NEFECON in South Korea
Published: 2022-03-14 (Crawled : 01:00) - prnewswire.com
CALT | $18.5 1.65% 1.62% 1.5K
|
Health Technology
|
| O: 3.44%
H: 0.0%
C: 0.0%
license therapeutics commercialization nefecon
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.